The Venture Capital Podcast with Fexingo · 2026-07-22 · 8 min
In this episode of The Venture Capital Podcast, Lucas and Luna dive into Dimension Capital's new $800 million fund, which is targeting the convergence of scientific research and high-performance computing. They explore why VCs are increasingly betting on startups that combine biology, chemistry, and AI, and discuss how this trend is reshaping venture capital itself. Lucas explains the shift from pure software to 'science-first' investing, while Luna questions whether this is a repeat of the billion-dollar lab-equipment startups of the past. They also touch on the broader market context, with big tech stocks like Alphabet and Meta down in the past week, and what that means for capital deployment. A must-listen for anyone tracking where venture dollars are flowing next. #DimensionCapital #VentureCapital #ScienceAndCompute #AI #Biotech #DeepTech #StartupInvesting #Fundraising #VCFirms #TechInvesting #Business #Technology #Podcast #FexingoBusiness #BusinessPodcast #VentureCapitalPodcast #TermSheets #StartupFunding Keep every episode free: buymeacoffee.com/fexingo
Other episodes covering the same guests and topics, from across The B2B Podcast Index.